AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor
- 1 September 2005
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 70 (5), 752-761
- https://doi.org/10.1016/j.bcp.2005.05.035
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studiesCytometry Part A, 2004
- AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptorNature Medicine, 1998
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4Antiviral Research, 1997
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsThe Journal of Experimental Medicine, 1997
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996
- Synthesis and Structure-Activity Relationships of Phenylenebis(methylene)-Linked Bis-Tetraazamacrocycles That Inhibit HIV Replication. Effects of Macrocyclic Ring Size and Substituents on the Aromatic LinkerJournal of Medicinal Chemistry, 1995
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990